Palantir Technologies Inc. Stock Falls Monday, Underperforms Market

Enzolytics Inc

Change company Symbol lookup

Select an option...

ENZC Enzolytics Inc

GREE Greenidge Generation Holdings Inc

MLM Martin Marietta Materials Inc

ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027

NRAC Noble Rock Acquisition Corp

DCGO DocGo Inc

VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028

MRC MRC Global Inc

BAC Bank of America Corp

BKR Baker Hughes Co

Company profile

Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused in developing monoclonal antibody therapy and treating infectious diseases. It has anti-HIV therapeutics and a methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The Company has clinically tested anti-HIV therapeutics. The Company has developed a cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus. The Company has also created human cell lines that produce human antibodies against other infectious diseases, including rabies, influenza, tetanus, and diphtheria. The Company is testing these antibodies to prepare them for use as therapies against these diseases.

Palantir Technologies Inc. Stock Falls Monday, Underperforms Market

5:18 pm ET January 10, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Palantir Technologies Inc. (PLTR) dropped 0.36% to $16.50 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.14% to 4,670.29 and Dow Jones Industrial Average falling 0.45% to 36,068.87. This was the stock's fifth consecutive day of losses. Palantir Technologies Inc. closed $28.50 short of its 52-week high ($45.00), which the company achieved on January 27th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Tyler Technologies Inc. (TYL) rose 0.58% to $486.41, Cognizant Technology Solutions Corp. (CTSH) fell 0.85% to $86.68, and Verint Systems Inc. (VRNT) fell 0.48% to $52.07. Trading volume (77.4 M) eclipsed its 50-day average volume of 38.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 10, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 10, 2022 17:18 ET (22:18 GMT)